Austin Health

Title
Investigating PSMA-PET/CT to resolve prostate MRI PIRADS4-5 and negative biopsy discordance.
Publication Date
2023-01-05
Author(s)
Wong, Lih-Ming
Koschel, Samantha
Whish-Wilson, Thomas
Farag, Matthew
Bolton, Damien M
Zargar, Homi
Corcoran, Niall
Lawrentschuk, Nathan
Christov, Alexandar
Thomas, Lauren
Perry, Elisa
Heinze, Stefan
Taubman, Kim
Sutherland, Tom
Subject
18F-DCPyL
PSMA-PET/CT
Prostate biopsy
Prostate cancer
mpMRI prostate
Type of document
Journal Article
OrcId
0000-0003-0490-7876
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
DOI
10.1007/s00345-022-04243-5
Abstract
To determine the utility of diagnostic 18F-DCPyL PSMA-PET/CT to aid management of men with highly suspicious multiparametric MRI prostate (PIRAD 4-5 lesions) and discrepant negative prostate biopsy.
Link
link
Citation
World Journal of Urology 2023, 41(2)
Jornal Title
World Journal of Urology
ISSN
1433-8726

Files:

NameSizeformatDescriptionLink